Phase I dose-escalation study of the pan-PI3 K inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors

  • M. Macy
  • , T. Cash
  • , N. Pinto
  • , J. G. Pressey
  • , L. Szalontay
  • , W. L. Furman
  • , A. Bukowinski
  • , J. H. Foster
  • , G. K. Friedman
  • , J. HaDuong
  • , E. Fox
  • , B. J. Weigel
  • , J. Grevel
  • , F. Huang
  • , C. Phelps
  • , B. H. Childs
  • , J. Chung
  • , S. Chaturvedi
  • , A. Schulz
  • , S. G. DuBois

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)S28-S29
JournalEuropean Journal of Cancer
Volume174
DOIs
StatePublished - Oct 2022

Cite this